ZURAZura Bio Limited Class A Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 24220
Ticker: ZURA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-03-21
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ZURA

Detail

Enriched 2026-08-14 20:47

Market cap: $553,892,411.86
Shares outstanding (class): 94,997,710
Shares outstanding (weighted): 95,829,137
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 40
Location: LA JOLLA, CA
Homepage: https://www.zurabio.com
Description: Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $4.44M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.90M	0.00%	486,850 NS	TICKER
iShares Micro-Cap ETF iShares Trust	IWC	$773.8K	0.06%	130,048 NS	TICKER
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$507.8K	0.59%	85,348 NS	TICKER
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$119.1K	0.00%	20,013 NS	TICKER
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$76.2K	0.01%	12,806 NS	TICKER
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$54.7K	0.03%	9,201 NS	TICKER
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$8.9K	0.00%	1,500 NS	TICKER
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$6.9K	0.00%	1,158 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERZURA
CIK0001855644
ISINKYG9TY5A1016
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Zura Bio is a clinical-stage biotechnology company developing immunology therapies, matching the BIOTECHNOLOGY industry under HEALTHCARE.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.